Atrion Corporation (ATRI)
Price:
459.92 USD
( + 0.26 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)

(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Akoya Biosciences, Inc.
VALUE SCORE:
0
2nd position
LeMaitre Vascular, Inc.
VALUE SCORE:
9
The best
Pro-Dex, Inc.
VALUE SCORE:
10
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
No data to display
No data to display
DESCRIPTION
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
NEWS

Smaller But Mighty: 3 Small-Cap Stocks for Long-Term Dividend Growth
investorplace.com
2024-08-14 07:30:00Generally speaking, small-cap stocks have market capitalizations below $2 billion. They tend to have stronger growth potential over the long run when compared to bigger companies in their respective industries.

Atrion's (ATRI) Q2 Earnings Plummet Y/Y on Nordson Merger Costs
zacks.com
2024-08-09 14:20:24Atrion's (ATRI) Q2 EPS drops to 23 cents, down from $3.73 year over year, as merger-related expenses with Nordson hit profits despite strong revenue growth in MPS and fluid delivery segments.

Atrion Reports Second Quarter 2024 Results
globenewswire.com
2024-08-08 18:00:00ALLEN, Texas, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the second quarter ended June 30, 2024.

ATRI ALERT: The M&A Class Action Firm Investigates the Merger and August 19, 2024 Shareholder Vote of Atrion Corporation
prnewswire.com
2024-07-29 09:17:00NEW YORK , July 29, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. (Nasdaq: ATRI ), relating to its proposed merger with Nordson Corporation.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATRI, CALT on Behalf of Shareholders
accesswire.com
2024-07-28 12:40:00NEW YORK, NY / ACCESSWIRE / July 28, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Atrion Corporation (NASDAQ: ATRI)'s sale to Nordson Corporation for $460.00 per share in cash. If you are an Atrion shareholder, click here to learn more about your legal rights and options.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATRI, HTLF on Behalf of Shareholders
globenewswire.com
2024-07-17 17:29:00NEW YORK, July 17, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

URGENT UPDATE: The M&A Class Action Firm Investigates Merger and Imminent Vote on August 19, 2024, of Atrion Corporation – ATRI
globenewswire.com
2024-07-16 17:08:00NEW YORK, July 16, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. ( Nasdaq : ATRI ), relating to its proposed merger with Nordson Corporation. Under the terms of the agreement, Atrion Corp. shareholders will receive $460.00 in cash per share of Atrion stock they hold.

URGENT UPDATE: The M&A Class Action Firm Investigates Merger and Imminent Vote on August 19, 2024, of Atrion Corporation - ATRI
prnewswire.com
2024-07-15 20:36:00NEW YORK , July 15, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. (Nasdaq: ATRI ), relating to its proposed merger with Nordson Corporation.

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Atrion Corporation – ATRI
globenewswire.com
2024-07-08 15:13:00NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. ( Nasdaq : ATRI ), relating to its proposed merger with Nordson Corporation. Under the terms of the agreement, Atrion Corp. shareholders will receive $460.00 in cash per share of Atrion stock they hold.

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Atrion Corporation - ATRI
prnewswire.com
2024-07-03 20:26:00NEW YORK , July 3, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. (Nasdaq: ATRI ), relating to its proposed merger with Nordson Corporation.

Zacks Initiates Coverage of Atrion With Neutral Recommendation
zacks.com
2024-06-07 08:46:15Discover why Zacks gives Atrion a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Uncover ATRI's impressive growth in the medical devices market and strong financials, alongside challenges like stiff competition in the medical devices market.

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Atrion Corporation
prnewswire.com
2024-05-28 17:45:00NEW YORK , May 28, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Atrion Corporation (NASDAQ: ATRI) and its board of directors concerning the proposed acquisition of the company by Nordson Corporation. Stockholders will receive $460 for each share of Atrion stock that they hold.

Shareholder Alert: Ademi LLP investigates whether Atrion Corporation has obtained a Fair Price for its Public Shareholders in its transaction with Nordson
prnewswire.com
2024-05-28 11:16:00MILWAUKEE , May 28, 2024 /PRNewswire/ -- Ademi LLP is investigating Atrion (Nasdaq: ATRI) for possible breaches of fiduciary duty and other violations of law in its transaction Nordson. Click here to learn how to join the https://www.ademilaw.com/case/atrion-corporation or call Guri Ademi toll-free at 866-264-3995.

ATRI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Atrion Corporation Is Fair to Shareholders
businesswire.com
2024-05-28 08:14:00NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Atrion Corporation (NASDAQ: ATRI) to Nordson Corporation for $460.00 per share in cash is fair to Atrion shareholders. Halper Sadeh encourages Atrion shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Atrion and i.

Atrion Corporation Enters Into Merger Agreement with Nordson Corporation
globenewswire.com
2024-05-28 07:24:00ALLEN, Texas, May 28, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million. The transaction enterprise value reflects a multiple of 20.2 times Atrion's 2023 EBITDA, and the $460 per share price represents a 15% premium to Atrion's 90-day average daily volume-weighted average stock price.

Nordson Corporation Announces Agreement to Acquire Atrion Corporation, a Market Leader in Medical Infusion and Cardiovascular Technologies
businesswire.com
2024-05-28 07:00:00WESTLAKE, Ohio--(BUSINESS WIRE)--Nordson Corporation (Nasdaq: NDSN) today announced that it has entered into a definitive agreement to acquire Atrion Corporation (Nasdaq: ATRI), a leader in proprietary medical infusion fluid delivery and niche cardiovascular solutions, for $460.00 per share in cash. This reflects a valuation of 15X Atrion's 2024 full-year estimated EBITDA, inclusive of synergies Nordson expects to generate in the first two years of its ownership. The acquisition expands Nordson.

Smaller But Mighty: 3 Small-Cap Stocks for Long-Term Dividend Growth
investorplace.com
2024-08-14 07:30:00Generally speaking, small-cap stocks have market capitalizations below $2 billion. They tend to have stronger growth potential over the long run when compared to bigger companies in their respective industries.

Atrion's (ATRI) Q2 Earnings Plummet Y/Y on Nordson Merger Costs
zacks.com
2024-08-09 14:20:24Atrion's (ATRI) Q2 EPS drops to 23 cents, down from $3.73 year over year, as merger-related expenses with Nordson hit profits despite strong revenue growth in MPS and fluid delivery segments.

Atrion Reports Second Quarter 2024 Results
globenewswire.com
2024-08-08 18:00:00ALLEN, Texas, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the second quarter ended June 30, 2024.

ATRI ALERT: The M&A Class Action Firm Investigates the Merger and August 19, 2024 Shareholder Vote of Atrion Corporation
prnewswire.com
2024-07-29 09:17:00NEW YORK , July 29, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. (Nasdaq: ATRI ), relating to its proposed merger with Nordson Corporation.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATRI, CALT on Behalf of Shareholders
accesswire.com
2024-07-28 12:40:00NEW YORK, NY / ACCESSWIRE / July 28, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Atrion Corporation (NASDAQ: ATRI)'s sale to Nordson Corporation for $460.00 per share in cash. If you are an Atrion shareholder, click here to learn more about your legal rights and options.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATRI, HTLF on Behalf of Shareholders
globenewswire.com
2024-07-17 17:29:00NEW YORK, July 17, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

URGENT UPDATE: The M&A Class Action Firm Investigates Merger and Imminent Vote on August 19, 2024, of Atrion Corporation – ATRI
globenewswire.com
2024-07-16 17:08:00NEW YORK, July 16, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. ( Nasdaq : ATRI ), relating to its proposed merger with Nordson Corporation. Under the terms of the agreement, Atrion Corp. shareholders will receive $460.00 in cash per share of Atrion stock they hold.

URGENT UPDATE: The M&A Class Action Firm Investigates Merger and Imminent Vote on August 19, 2024, of Atrion Corporation - ATRI
prnewswire.com
2024-07-15 20:36:00NEW YORK , July 15, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. (Nasdaq: ATRI ), relating to its proposed merger with Nordson Corporation.

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Atrion Corporation – ATRI
globenewswire.com
2024-07-08 15:13:00NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. ( Nasdaq : ATRI ), relating to its proposed merger with Nordson Corporation. Under the terms of the agreement, Atrion Corp. shareholders will receive $460.00 in cash per share of Atrion stock they hold.

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Atrion Corporation - ATRI
prnewswire.com
2024-07-03 20:26:00NEW YORK , July 3, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. (Nasdaq: ATRI ), relating to its proposed merger with Nordson Corporation.

Zacks Initiates Coverage of Atrion With Neutral Recommendation
zacks.com
2024-06-07 08:46:15Discover why Zacks gives Atrion a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Uncover ATRI's impressive growth in the medical devices market and strong financials, alongside challenges like stiff competition in the medical devices market.

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Atrion Corporation
prnewswire.com
2024-05-28 17:45:00NEW YORK , May 28, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Atrion Corporation (NASDAQ: ATRI) and its board of directors concerning the proposed acquisition of the company by Nordson Corporation. Stockholders will receive $460 for each share of Atrion stock that they hold.

Shareholder Alert: Ademi LLP investigates whether Atrion Corporation has obtained a Fair Price for its Public Shareholders in its transaction with Nordson
prnewswire.com
2024-05-28 11:16:00MILWAUKEE , May 28, 2024 /PRNewswire/ -- Ademi LLP is investigating Atrion (Nasdaq: ATRI) for possible breaches of fiduciary duty and other violations of law in its transaction Nordson. Click here to learn how to join the https://www.ademilaw.com/case/atrion-corporation or call Guri Ademi toll-free at 866-264-3995.

ATRI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Atrion Corporation Is Fair to Shareholders
businesswire.com
2024-05-28 08:14:00NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Atrion Corporation (NASDAQ: ATRI) to Nordson Corporation for $460.00 per share in cash is fair to Atrion shareholders. Halper Sadeh encourages Atrion shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Atrion and i.

Atrion Corporation Enters Into Merger Agreement with Nordson Corporation
globenewswire.com
2024-05-28 07:24:00ALLEN, Texas, May 28, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million. The transaction enterprise value reflects a multiple of 20.2 times Atrion's 2023 EBITDA, and the $460 per share price represents a 15% premium to Atrion's 90-day average daily volume-weighted average stock price.

Nordson Corporation Announces Agreement to Acquire Atrion Corporation, a Market Leader in Medical Infusion and Cardiovascular Technologies
businesswire.com
2024-05-28 07:00:00WESTLAKE, Ohio--(BUSINESS WIRE)--Nordson Corporation (Nasdaq: NDSN) today announced that it has entered into a definitive agreement to acquire Atrion Corporation (Nasdaq: ATRI), a leader in proprietary medical infusion fluid delivery and niche cardiovascular solutions, for $460.00 per share in cash. This reflects a valuation of 15X Atrion's 2024 full-year estimated EBITDA, inclusive of synergies Nordson expects to generate in the first two years of its ownership. The acquisition expands Nordson.